These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug-Drug Interaction Perpetrators. Marok FZ; Wojtyniak JG; Fuhr LM; Selzer D; Schwab M; Weiss J; Haefeli WE; Lehr T Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840001 [TBL] [Abstract][Full Text] [Related]
105. Longer-term breastfeeding outcomes associated with domperidone use for lactation differs according to maternal weight. Grzeskowiak LE; Amir LH; Smithers LG Eur J Clin Pharmacol; 2018 Aug; 74(8):1071-1075. PubMed ID: 29725699 [TBL] [Abstract][Full Text] [Related]
106. Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information. Mishra H; Polak S; Jamei M; Rostami-Hodjegan A CPT Pharmacometrics Syst Pharmacol; 2014 Aug; 3(8):e130. PubMed ID: 25116274 [TBL] [Abstract][Full Text] [Related]
107. Treating nausea and vomiting in palliative care: a review. Glare P; Miller J; Nikolova T; Tickoo R Clin Interv Aging; 2011; 6():243-59. PubMed ID: 21966219 [TBL] [Abstract][Full Text] [Related]
108. Treatment of nausea and vomiting in terminally ill cancer patients. Glare PA; Dunwoodie D; Clark K; Ward A; Yates P; Ryan S; Hardy JR Drugs; 2008; 68(18):2575-90. PubMed ID: 19093700 [TBL] [Abstract][Full Text] [Related]
109. Population pharmacokinetics of domperidone in preterm neonates. Dailly E; Drouineau MH; Gournay V; Rozé JC; Jolliet P Eur J Clin Pharmacol; 2008 Dec; 64(12):1197-200. PubMed ID: 18685840 [TBL] [Abstract][Full Text] [Related]
110. Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers. Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 2007 Nov; 64(5):591-602. PubMed ID: 17578485 [TBL] [Abstract][Full Text] [Related]
111. Biowaivers for oral immediate-release products: implications of linear pharmacokinetics. Faassen F; Vromans H Clin Pharmacokinet; 2004; 43(15):1117-26. PubMed ID: 15568890 [TBL] [Abstract][Full Text] [Related]
112. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers. Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072 [TBL] [Abstract][Full Text] [Related]
113. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). Lauritsen K; Laursen LS; Rask-Madsen J Clin Pharmacokinet; 1990 Aug; 19(2):94-125. PubMed ID: 2199130 [TBL] [Abstract][Full Text] [Related]
114. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
115. Development of a sensitive UPLC-MS/MS assay for domperidone and pharmacokinetics of domperidone tablet formulations in fasting and fed Chinese healthy subjects . Wang C; Qin Z; Ren G; Zhai Y; Fu K; Lu C; Yang C; Chen X Int J Clin Pharmacol Ther; 2020 Mar; 58(3):177-182. PubMed ID: 31933472 [TBL] [Abstract][Full Text] [Related]
116. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152 [TBL] [Abstract][Full Text] [Related]